Birdwatch Note
2024-03-08 02:42:53 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
日本におけるワクチンの予防効果は再三再四報告されXBBワクチンの効果も既に報告されています。症例数は極めて限定的としていますが、未接種者との比較で73.2%の入院予防効果があったとしています↓ https://www.tm.nagasaki-u.ac.jp/versus/results/20240228.pdf なお投稿者が挙げた厚労省の表は接種者の検査受け易さや未接種者と接種者は住んでいる地域の偏在が違うといった無数の交絡要因を統制してない結果である事に注意が必要です 国内でも濃厚接触者等の特定対象者を全員検査し検査受け易さ等のバイアスを除いた3研究でオミクロン初期株で3回接種者が未接種者に比べ陽性が少ない事が一貫して確認されている事に注意が必要です↓ https://pubmed.ncbi.nlm.nih.gov/36016171/ https://pubmed.ncbi.nlm.nih.gov/35948626/ https://pubmed.ncbi.nlm.nih.gov/36435404/
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1765872312241537322
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1765931163305345208
- noteId - 1765931163305345208
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1709865773404
- tweetId - 1765872312241537322
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 日本におけるワクチンの予防効果は再三再四報告されXBBワクチンの効果も既に報告されています。症例数は極めて限定的としていますが、未接種者との比較で73.2%の入院予防効果があったとしています↓ https://www.tm.nagasaki-u.ac.jp/versus/results/20240228.pdf なお投稿者が挙げた厚労省の表は接種者の検査受け易さや未接種者と接種者は住んでいる地域の偏在が違うといった無数の交絡要因を統制してない結果である事に注意が必要です 国内でも濃厚接触者等の特定対象者を全員検査し検査受け易さ等のバイアスを除いた3研究でオミクロン初期株で3回接種者が未接種者に比べ陽性が少ない事が一貫して確認されている事に注意が必要です↓ https://pubmed.ncbi.nlm.nih.gov/36016171/ https://pubmed.ncbi.nlm.nih.gov/35948626/ https://pubmed.ncbi.nlm.nih.gov/36435404/
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2024-03-08 02:42:53 UTC (1709865773404) |
2024-03-08 10:58:41 UTC (1709895521349) |
CURRENTLY_RATED_HELPFUL | 2024-03-10 02:46:15 UTC (1710038775311) |
CURRENTLY_RATED_HELPFUL | 2024-03-08 10:58:41 UTC (1709895521349) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2024-03-09 12:31:44 -0600 | Rating Details | |
2024-03-08 17:28:18 -0600 | Rating Details | |
2024-03-08 07:47:12 -0600 | Rating Details | |
2024-03-08 07:13:36 -0600 | Rating Details | |
2024-03-08 02:37:57 -0600 | Rating Details | |
2024-03-08 02:28:17 -0600 | Rating Details | |
2024-03-08 00:57:17 -0600 | Rating Details | |
2024-03-08 00:04:12 -0600 | Rating Details | |
2024-03-07 23:18:54 -0600 | Rating Details | |
2024-03-07 23:13:49 -0600 | Rating Details | |
2024-03-07 21:56:52 -0600 | Rating Details | |
2024-03-07 21:41:53 -0600 | Rating Details | |
2024-03-07 21:39:58 -0600 | Rating Details | |
2024-03-07 21:38:42 -0600 | Rating Details | |
2024-03-07 21:36:13 -0600 | Rating Details | |
2024-03-07 21:35:44 -0600 | Rating Details | |
2024-03-07 21:30:17 -0600 | Rating Details | |
2024-03-07 21:19:07 -0600 | Rating Details | |
2024-03-07 21:13:10 -0600 | Rating Details | |
2024-03-07 21:12:20 -0600 | Rating Details | |
2024-03-07 21:11:31 -0600 | Rating Details | |
2024-03-07 21:10:33 -0600 | Rating Details | |
2024-03-07 21:08:43 -0600 | Rating Details | |
2024-03-07 21:07:44 -0600 | Rating Details | |
2024-03-07 21:07:40 -0600 | Rating Details | |
2024-03-07 21:04:15 -0600 | Rating Details | |
2024-03-09 09:26:49 -0600 | Rating Details | |
2024-03-08 08:41:02 -0600 | Rating Details | |
2024-03-08 07:57:26 -0600 | Rating Details | |
2024-03-08 03:07:09 -0600 | Rating Details | |
2024-03-08 02:14:13 -0600 | Rating Details | |
2024-03-08 00:14:22 -0600 | Rating Details | |
2024-03-08 00:05:16 -0600 | Rating Details | |
2024-03-08 00:01:36 -0600 | Rating Details | |
2024-03-07 23:58:14 -0600 | Rating Details | |
2024-03-07 23:17:03 -0600 | Rating Details | |
2024-03-07 22:45:49 -0600 | Rating Details | |
2024-03-07 22:37:22 -0600 | Rating Details | |
2024-03-07 22:26:19 -0600 | Rating Details | |
2024-03-07 21:58:15 -0600 | Rating Details | |
2024-03-07 21:56:20 -0600 | Rating Details | |
2024-03-07 21:47:17 -0600 | Rating Details | |
2024-03-07 21:43:34 -0600 | Rating Details | |
2024-03-07 21:39:08 -0600 | Rating Details | |
2024-03-07 21:23:37 -0600 | Rating Details | |
2024-03-07 21:19:39 -0600 | Rating Details | |
2024-03-07 21:18:58 -0600 | Rating Details | |
2024-03-07 21:16:47 -0600 | Rating Details | |
2024-03-07 21:13:21 -0600 | Rating Details | |
2024-03-07 21:11:35 -0600 | Rating Details | |
2024-03-07 21:09:45 -0600 | Rating Details | |
2024-03-07 21:09:32 -0600 | Rating Details | |
2024-03-07 21:05:45 -0600 | Rating Details | |
2024-03-07 21:03:40 -0600 | Rating Details | |
2024-03-07 21:02:29 -0600 | Rating Details | |
2024-03-07 20:55:23 -0600 | Rating Details | |
2024-03-07 20:50:26 -0600 | Rating Details | |
2024-03-07 20:48:36 -0600 | Rating Details | |
2024-03-08 17:09:14 -0600 | Rating Details | |
2024-03-08 12:06:51 -0600 | Rating Details | |
2024-03-08 05:06:58 -0600 | Rating Details | |
2024-03-08 01:00:49 -0600 | Rating Details | |
2024-03-08 00:15:41 -0600 | Rating Details | |
2024-03-08 00:05:13 -0600 | Rating Details | |
2024-03-07 23:59:20 -0600 | Rating Details | |
2024-03-07 23:09:52 -0600 | Rating Details | |
2024-03-07 23:01:25 -0600 | Rating Details | |
2024-03-07 22:21:42 -0600 | Rating Details | |
2024-03-07 22:13:45 -0600 | Rating Details | |
2024-03-07 22:12:34 -0600 | Rating Details | |
2024-03-07 22:00:13 -0600 | Rating Details | |
2024-03-07 21:44:58 -0600 | Rating Details | |
2024-03-07 21:38:38 -0600 | Rating Details | |
2024-03-07 21:35:14 -0600 | Rating Details | |
2024-03-07 21:24:24 -0600 | Rating Details | |
2024-03-07 21:24:06 -0600 | Rating Details | |
2024-03-07 21:23:30 -0600 | Rating Details | |
2024-03-07 21:17:00 -0600 | Rating Details | |
2024-03-07 21:14:44 -0600 | Rating Details | |
2024-03-07 21:12:09 -0600 | Rating Details | |
2024-03-07 21:11:38 -0600 | Rating Details | |
2024-03-07 21:10:23 -0600 | Rating Details | |
2024-03-07 21:03:17 -0600 | Rating Details | |
2024-03-07 20:57:17 -0600 | Rating Details | |
2024-03-07 20:50:41 -0600 | Rating Details | |
2024-03-07 20:50:12 -0600 | Rating Details | |
2024-03-12 06:03:18 -0500 | Rating Details | |
2024-03-10 23:40:40 -0500 | Rating Details | |
2024-05-04 09:03:14 -0500 | Rating Details |